Crohn Disease - 44 Studies Found Active, not recruiting : A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease : Crohn's Disease : 2014-01-09 : Drug: E6011 2 mg/kg Drug: E6011 5 mg/kg Completed : Study for the Treatment of Crohn's Disease With Adacolumn : Crohn's Disease : 2005-09-09 : Device: Adacolumn Active, not recruiting : Extension Study of MT-1303 in Subjects With Crohn's Disease : Crohn's Disease : 2015-03-10 : Drug: MT-1303 Completed : Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity : Crohn's Disease : 2007-07-02 : Procedure: Fecal calprotectin Recruiting : Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease : Crohn's Disease : 2014-07-16 : Dietary Supplement: Placebo 1 Completed : Safety and Maintenance Study of Entocort for Children With Crohn's Disease : Crohn's Disease : 2011-10-14 : Drug: Entocort Entocort capsules, taken orally, 6 mg daily. Completed : An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease : Crohn Disease : 2005-12-22 : Drug: Infliximab 5 mg/kg Infli Terminated : Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease : Crohn's Disease : 2005-08-12 : Drug: Nitazoxanide One nitazox Completed : Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease : Crohn's Disease : 2014-05-20 : Drug: MT-1303 Completed : A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease : Crohn Disease : 2005-09-13 : Drug: infliximab or placebo <<< Previous | Next >>>
